Sunflower Pharmaceutical Group Co.,Ltd (SHE:002737)
China
· Delayed Price · Currency is CNY 13.68
+0.05 (0.37%)
Mar 10, 2026, 3:04 PM CST
SHE:002737 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,989 | 11,966 | 15,172 | 13,469 | 9,495 | 8,527 | Upgrade
|
| Market Cap Growth | -25.04% | -21.13% | 12.65% | 41.85% | 11.35% | -1.07% | Upgrade
|
| Enterprise Value | 6,005 | 9,998 | 12,304 | 11,449 | 8,001 | 7,623 | Upgrade
|
| Last Close Price | 13.68 | 19.86 | 23.89 | 20.50 | 13.94 | 12.15 | Upgrade
|
| PE Ratio | - | 24.32 | 13.56 | 15.53 | 13.47 | 14.59 | Upgrade
|
| Forward PE | - | 10.63 | 10.63 | 10.63 | 10.63 | 10.63 | Upgrade
|
| PS Ratio | 3.82 | 3.54 | 2.66 | 2.64 | 2.13 | 2.46 | Upgrade
|
| PB Ratio | 1.89 | 2.61 | 3.03 | 3.03 | 2.41 | 2.52 | Upgrade
|
| P/TBV Ratio | 2.19 | 3.02 | 3.51 | 3.60 | 2.91 | 3.17 | Upgrade
|
| P/FCF Ratio | 34.84 | - | 20.49 | 7.39 | 12.71 | 8.91 | Upgrade
|
| P/OCF Ratio | 25.60 | - | 17.05 | 6.82 | 10.97 | 7.29 | Upgrade
|
| EV/Sales Ratio | 2.87 | 2.96 | 2.16 | 2.25 | 1.79 | 2.20 | Upgrade
|
| EV/EBITDA Ratio | - | 15.98 | 9.06 | 8.91 | 8.55 | 9.40 | Upgrade
|
| EV/EBIT Ratio | - | 22.08 | 10.40 | 11.20 | 10.37 | 11.52 | Upgrade
|
| EV/FCF Ratio | 26.19 | - | 16.62 | 6.28 | 10.71 | 7.97 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.00 | 0.01 | 0.10 | 0.06 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.01 | 0.02 | 0.34 | 0.26 | 0.38 | Upgrade
|
| Debt / FCF Ratio | 0.10 | - | 0.04 | 0.24 | 0.33 | 0.32 | Upgrade
|
| Net Debt / Equity Ratio | -0.51 | -0.50 | -0.71 | -0.77 | -0.52 | -0.44 | Upgrade
|
| Net Debt / EBITDA Ratio | 19.66 | -3.66 | -2.63 | -2.65 | -2.19 | -1.83 | Upgrade
|
| Net Debt / FCF Ratio | -9.44 | 5.72 | -4.83 | -1.87 | -2.74 | -1.55 | Upgrade
|
| Asset Turnover | 0.38 | 0.53 | 0.82 | 0.80 | 0.83 | 0.66 | Upgrade
|
| Inventory Turnover | 1.90 | 2.18 | 3.31 | 3.22 | 2.87 | 2.36 | Upgrade
|
| Quick Ratio | 3.43 | 2.82 | 2.47 | 1.87 | 2.06 | 1.82 | Upgrade
|
| Current Ratio | 4.53 | 3.78 | 3.15 | 2.24 | 2.71 | 2.54 | Upgrade
|
| Return on Equity (ROE) | -3.33% | 10.48% | 24.67% | 21.73% | 20.81% | 18.18% | Upgrade
|
| Return on Assets (ROA) | -3.18% | 4.45% | 10.63% | 10.09% | 8.97% | 7.94% | Upgrade
|
| Return on Invested Capital (ROIC) | -13.72% | 19.24% | 82.86% | 59.06% | 34.70% | 26.18% | Upgrade
|
| Return on Capital Employed (ROCE) | -6.40% | 9.40% | 22.10% | 21.10% | 17.60% | 16.70% | Upgrade
|
| Earnings Yield | -1.61% | 4.11% | 7.38% | 6.44% | 7.42% | 6.85% | Upgrade
|
| FCF Yield | 2.87% | -3.35% | 4.88% | 13.53% | 7.87% | 11.22% | Upgrade
|
| Dividend Yield | 3.67% | 2.52% | 6.28% | 4.88% | 5.02% | 2.88% | Upgrade
|
| Payout Ratio | - | 179.90% | 52.59% | 48.05% | 30.11% | 101.64% | Upgrade
|
| Buyback Yield / Dilution | 4.05% | -0.49% | 0.53% | -0.61% | 0.35% | -0.27% | Upgrade
|
| Total Shareholder Return | 7.73% | 2.02% | 6.80% | 4.27% | 5.37% | 2.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.